Epstein-Barr virus strain characterization

APMIS

Volumn 106, Issue 4, 1998, Pages 425-433

  Munch, Mette ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Ebnotype; Epstein Barr virus; Herpesvirus; PCR; Strain; Type

Indexed keywords

BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; INFECTIOUS MONONUCLEOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; VIRUS REACTIVATION; VIRUS STRAIN; VIRUS TYPING;

EID: 0031800103     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01367.x     Document Type: Review

References (59)

1. Abdel-Hamid, M., Chen, J. J., Constantine, N., Massoud, M. & Raab-Raub, N.: EBV strain variation: geographical distribution and relation to disease state. Virology 190: 168-175, 1992.
2. Allday, M. L. & MacGillivray, A. J.: Epstein-Barr virus nuclear antigen (EBNA): Size polymorphism of EBNA1. J. Gen. Virol. 66: 1595-1600, 1985.
3. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C., Tuffnell, P. S. & Barrell, B. G.: DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207-211, 1984.
4. Baichwal, K. R. & Sugden, B.: Transformation of Balb 3T3 by the BNLF1 gene of Epstein-Barr virus. Oncogene 2: 461-467, 1988.
5. Birx, D. L., Redfield, R. R. & Tosato, G.: Defective regulation of Epstein-Barr virus infection in human immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med. 314: 874-879, 1986.
6. Bhatia, K., Raj, A., Gutièrrez, M. I., Judde, J.-G., Spangler, G., Venkatesh, H. & Magrath, I. T.: Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13: 177-181, 1996.
7. Braun, D. K., Dominguez, G. & Pellett, P. E.: Human herpesvirus 6. Clin. Microbiol. Rev. 10: 521-567, 1997.
8. Buisson, M., Morand, P., Genoulaz, O., Bourgeat, M.-J., Micoud, M. & Seigneurin, J.-M.: Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J. Gen. Virol. 75: 431-437, 1994.
9. Burrows, J. M., Khanna, R., Sculley, T. B., Alpers, M. P., Moss, D. J. & Burrows, S. R.: Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70: 4829-4833, 1996.
10. Campos-Lima, P. O., Levitsky, V., Brooks, J., Lee, S. P., Hu, L. F., Rickinson, A. B. & Masucci, M. G.: T cell responses and virus evolution: Loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 779: 1297-1305, 1994.
11. Campos-Lima, P.-O., Levitsky, V., Imreh, M. P., Gavioli, R. & Masucci, M. G.: Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 186: 83-89, 1997.
12. Chen, M.-L., Tsai, C.-N., Liang, C.-L., Huang, C.-R., Sulitzeanu, D., Liu, S.-T. & Chang, Y.-S.: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7: 2131-2140, 1992.
13. Dambaugh, T., Hennessy, K., Chamnaukit, L. & Kieff, E.: U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81: 7632-7636, 1984.
14. Decker, L. L., Klaman, L. D. & Thorley-Lawson, D. A.: Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70: 3286-3289, 1996.
15. Ernberg, I., Danell, E., Gratama, J. W., Oosterveer, M. A. P. & Klein, G.: Molecular weight variation of EBNAs as a means to identify different Epstein-Barr virus isolates (EBNO-typing). In: Ablashi, D. V. (Ed.): Epstein-Barr virus and human disease. The Humana press, Clifton, N. J. 1988, pp. 341-347.
16. Falk, K., Gratama, J. W., Rowe, M., Zou, J. Z., Khanim, F., Young, L. S., Oosterveer, M. A. P. & Ernberg, I.: The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J. Gen. Virol. 76: 779-790, 1995.
17. Falk, K., Zou, J. Z., Luchi, E., Linde, A. & Ernberg, I.: Direct identification by PCR of EBV types and variants in clinical samples. J. Med. Virol. 51: 355-363, 1997.
18. Farrell, P. J.: Epstein-Barr virus genome. In: Klein, G. (Ed.): Advances in Viral Oncology 8: 1989, pp. 103-132.
19. Gavioli, R., Kurilla, M. G., Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., Rickinson, A. B. & Masucci, M. G.: Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67: 1572-1578, 1993.
20. Gratama, J. W., Oosterveer, M. A. P., Klein, G. & Ernberg, I.: EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J. Virol. 64: 4703-4708, 1990.
21. Gratama, J. W., Lennette, E. T., Lønnqvist, B., Oosterveer, M. A. P., Klein, G., Ringden, O. & Ernberg, I.: Detection of multiple Epstein-Barr viral strains in allogenic bone marrow transplant recipients. J. Med. Virol. 37: 39-47, 1992.
22. Gratama, J. W., Oosterveer, M. A. P., Weimar, W., Sintnicolaos, K., Sizoo, W., Bolhuis, R. L. H. & Ernberg, I.: Detection of multiple "Ebnotypes" in individual Epstein-Barr carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J. Gen. Virol. 75: 85-94, 1994.
23. Gratama, J. W. & Ernberg, I.: Molecular epidemiology of Epstein-Barr virus infection. In: Woude, G. F. F. & Klein, G. (Eds.): Advances in Cancer Research 67, San Diego, CA, Academic Press 1995, pp. 197-255.
24. Herbst, H., Dallenbach, F. & Hummel, M.: Epstein-Barr virus membrane antigen expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 88: 4766-4770, 1991.
25. Hu, L.-F., Zabarovsky, E. R., Chen, F., Cao, S.-L., Ernberg, I., Klein, G. & Winberg, G.: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 72: 2399-2409, 1991.
26. Hu, L.-F., Chen, F., Zheng, X., Ernberg, J., Cao, S.-L., Christensson, B., Klein, G. & Winberg, G.: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8: 1575-1583, 1993.
27. Katz, B. Z., Andiman, W. A., Eastman, R., Martin, K. & Miller, G.: Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system. J. Infect. Dis. 153: 601-604, 1986.
28. Katz, B. Z., Mederman, J. C., Olson, B. A. & Miller, G.: Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts. J. Infect. Dis. 157: 299-308, 1988.
29. Khanim, F., Yao, Q.-Y., Niedobitek, G., Sihota, S., Rickinson, A. B. & Young, L. S.: Analysis of Epstein-Barr virus gene polymorphism in normal donors and in virus-associated tumors from different geographic locations. Blood 88: 3491-3501, 1996.
30. Knecht, H., Bachmann, E., Brousset, P., Sandvej, K., Nadal, D., Bachmann, F., Odermann, B. F., Delsol, G. & Pallesen, G.: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82: 2937-2942, 1993.
31. Knecht, H., Brousset, P., Bachmann, E., Sandvej, K. & Odermatt, B. F.: Latent membrane protein 1: a key oncogene in EBV-related carcinogenesis? Review. Acta. Haematol. 90: 167-171, 1993.
32. Lung, M. L., Chang, R. S. & Jones, J. H.: Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. J. Virol. 62: 3862-3866, 1988.
33. Lung, M. L., Chang, R. S., Huang, M. L., Guo, H., Choy, D., Sam, J., Isao, S. Y., Cheng, P. & Hong, M.: Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in Southern China. Virology 177: 44-53, 1990.
34. Lung, M. L., Chang, G. C., Miller, T. R., Wara, W. M. & Phillips, T. L.: Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int. J. Cancer 59: 743-746, 1994.
35. Miller, W. E., Edwards, R. H., Walling, D. M. & Raab-Traub, N.: Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75: 2729-2740, 1994.
36. Moorthy, R. K. & Thorley-Lawson, D. A.: All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67: 1638-1646, 1993.
37. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. & Rickinson, A. B.: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for immune control of EBV-positive malignancies. J. Exp. Med. 176: 157-168, 1992.
38. Nilsson, K., Klein, G., Henle, W. & Henle, G.: The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer 8: 443-450 1971.
39. Packham, G., Brimmell, M., Cook, D., Sinclair, A. J. & Farrell, P. J.: Strain variation in Epstein-Barr virus immediate early genes. Virology 192: 541-550, 1993.
40. Rickinson, A. B., Young, L. S. & Rowe, M.: Influence of the Epstein-Barr virus nuclear antigen 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61: 1310-1317, 1987.
41. Rickinson, A. B. & Kieff, E.: Epstein-Barr virus. In: Fields, B. N., Knipe, D. M. & Howley, P. M. (Eds.): Fields Virology. Lippincott-Raven Publishers, Philadelphia, New York 1996, pp. 2397-2446.
42. Ring, C. J. A.: The B cell-immortalizing functions of Epstein-Barr virus. J. Gen. Virol. 75: 1-13, 1994.
43. Rowe, M., Young, L. S., Cadwallader, K., Petti, L., Kieff, E. & Rickinson, A. B.: Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 63: 1031-1039, 1989.
44. Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A. B. & Kieff, E.: Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64: 4084-4092, 1990.
45. Sandvej, K., Peh, S. C., Andresen, B. & Pallesen, G.: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30 bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 75: 4053-4060, 1994.
46. Sandvej, K., Munch, M. & Hamilton-Dutoit, S.: Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parametres and tumorigenicity in SCID and nude mice. J. Clin. Pathol. 49: 290-297 1996.
47. Sandvej, K., Gratama, J. W., Munch, M., Zhou, X.-G., Bolhuis, R. L. H., Andresen, B. S., Gregersen, N. & Hamilton-Dutoit, S.: Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promotor region: Identification of four variants among wild-type EBV isolates. Blood 90: 323-330, 1997.
48. Sculley, T. B., Moss, D. J., Hazelton, R. A. & Pope, J. H.: Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines "spontaneously" derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls. J. Gen. Virol. 68: 2069-2078, 1987.
49. Sculley, T. B., Apolloni, A., Hurren, L., Moss, D. J. & Cooper, D. A.: Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J. Infect. Dis. 162: 643-648, 1990.
50. Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A. & Pagano, J. S.: Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310: 1225-1230, 1984.
51. Vaughan, J. H.: The Epstein-Barr virus in autoimmunity. Springer Semin. Immunopathol. 17: 203-230, 1995.
52. Walling, D. M., Edmiston, S. N., Sixbey, J. W., Abdel-Hamid, M., Resnick, L. & Raab-Traub, N.: Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc. Natl. Acad. Sci. USA 89: 6560-6564, 1992.
53. Walling, D. M., Perkins, A. G., Webster-Cyriaque, J., Resnick, L. & Raab-Traub, N.: The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: Strain variation, genetic recombination, and transcriptional expression. J. Virol. 68: 7918-7926, 1994.
54. Wang, D., Liebowitz, D. & Kieff, E.: An EBV membrane protein expressed in immortalized lymphocytes transforms established cells. Cell 43: 831-840, 1985.
55. Wrightham, M. N., Stewart, J. P., Janjua, N. J., Pepper, S. D. V., Sample, C., Rooney, C. M. & Arrand, J. R.: Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208: 521-530, 1995.
56. Yao, Q. Y., Rickinson, A. B. & Epstein, M. A.: A reexamination of the Epstein-Barr virus carrier state in healthy seropositive donors. Int. J. Cancer 35: 35-42, 1985.
57. Yao, Q. Y., Czarnecka, H. & Rickinson, A. B.: Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities. Int. J. Cancer 48: 253-257, 1991a.
58. Yao, Q. Y., Rowe, M., Martin, B., Young, L. S. & Rickinson, A. B.: The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. Gen. Virol. 72: 1579-1590, 1991b.
59. Yao, Q . Y., Tierney, R. J., Croom-Carter, D., Cooper, G. M., Ellis, C. J., Rowe, M. & Rickinson, A. B.: Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. 70: 4895-4903, 1996.